PaDiSys logo
PaDiSys About Header
NowPos presents PaDiSys 2.3, for Patient Data Capture and Treatment Adherence using Mobile Technology at the Partnerships in Clinical Trials, at Orlando, Florida. Meet us at booth no. 326, from 21st - 24th April, 2013

NowPos will showcase its "PaDiSys Solution" for Treatment Programs and Clinical Research and Custom Application Development capabilities for Healthcare.

The service offerings showcased in the mHealth conference would be in the areas of mobile health (mHealth), mobile patient reported outcome (mPRO), mobile Treatment Adherence (mTA), custom mobile technology development on iPhone, Android, Symbian, j2me and advanced Electronic Health Records-EHR, Medical Health Records- MHR using mobile phone technology.

Don't forget to visit us at booth no. 326 and mail to us at for a pre-scheduled meeting.

TAKE Solutions announced its first implementation of Mobile-based Patient Diary System (PaDiSys)

Source: moneycontrol

Chennai, India – January 22, 2013 – TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a leader in Life Sciences solutions and services, today announced its first implementation of the mobile patient reported outcomes tool PaDiSys for a biopharmaceutical company focused on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. TAKE is the exclusive reseller worldwide of PaDiSys through a strategic partnership with NowPos, a company that specializes in developing mobile-based solutions for Life Sciences.

The PaDiSys (Patient Diary System) solution helps sponsors to improve patients' treatment adherence and compliance towards the protocol and patient reported outcomes. PaDiSys allows sponsors to walk away from a paper based approach to filling out questionnaires and assessments during clinical trials, thereby enabling the clinical staff to closely monitor patient compliance and safety. Clinicians and Site staff are equipped with easy-to-use analytical dashboards that monitor patient data in real time, and can intervene when necessary to ensure compliance. With quick deployment, implementation and simple use for both subjects and clinicians, there is a much higher adherence to a study regimen, thus improving trial compliance.

"TAKE has been providing solutions and services to life sciences customers for 12 years, and safety is one of our core areas of expertise," said Ram Yeleswarapu, President & CEO. "In partnership with NowPos, we can provide biopharmaceutical companies with cutting edge mobile technology and quality, while reducing costs and accelerating trial execution." The PaDiSys platform caters to clinical research studies across therapeutic areas. Flexible configuration allows the product to be used in different types of research, ranging from drug efficacy, behavioral, observational, adherence, quality of life, or lifestyle based studies in various therapeutic areas.

"PaDiSys was developed from the ground up by embracing key aspects of mobile technology and the need for a low cost turnkey solution," said Vikram Marla, CEO of NowPos M-Solutions. "Our strategic partnership with TAKE, along with their vast network of clients, is helping us reach out to the core Pharmaceutical community needing to improve their PRO and study compliance by many folds."


NowPos specializes in the development of products and custom applications using mobile technology in the field of life sciences. PaDiSys is a patient diary system designed to capture patient reported outcome (PRO) and help patients manage their treatment adherence, thereby enabling clinicians to perform timely intervention during regulated clinical trials and outcomes research studies. NowPos has its global headquarters in Hyderabad, India; its US Headquarters is located in Oak Park, CA.


TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes. TAKE has been recognized as a leader by IDC's MarketScape Worldwide Life Sciences R&D IT Outsourcing for 2011. TAKE's global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers globally. For more information, please visit

Show More

NowPos Speaks

Vikram Marla, CEO, NowPos speaks at the "The iMedicine & Mobile Life Sciences World Summit" at Boston on May 16th, 2012. His session addresses how smart phones can be effectively used to manage treatment adherence, capture patient assessment data and monitor patients during clinical trials, thus assisting investigators better manage their studies in a shorter study cycle and at a much lower cost. Benefits of using Smart Phones will be illustrated using studies performed by various investigators in multiple countries. Be there to know more and interact with Vikram. To book an appointment send in an email to

Mobile solutions in Clinical Trials

Source: Expresspharmaonline

Mobile phones are "always there always on", so why not use them to enhance patient compliance, trial effectiveness and reduce trial cost, asks Vikrant Patnaik, Senior Manager, Global Marketing and Communications NowPos M-Solutions